HEAD AND NECK-CANCER - PRESENT STATUS AND FUTURE-PROSPECTS OF ADJUVANT CHEMOTHERAPY

被引:23
作者
ALSARRAF, M
HUSSEIN, M
机构
[1] Division of Hematology and Oncology Department of Internal Medicine, Wayne State University and Harper Hospital, Detroit, MI
关键词
D O I
10.3109/07357909509024894
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For more than 15 years, active clinical research and continuing efforts in the field of CT in head and neck cancer have produced a modest but definite progress and achievements in this disease. We are a long way away from producing more definitive and acceptable results and higher cure rates in this disease. The achievements of systemic CT in patients with head and neck cancers are summarized in this review. Continuing efforts and investigation are needed to study the efficacy of systemic CT in patients with resectable head and neck cancer. We are continuing to investigate the best timing and sequence of CT as part of CMT and then the efficacy of such treatment in patients with resectable cancer. Efforts are underway to improve on the results in patients with NPC and patients with unresectable disease with the use of chemotherapy as part of CMT. Efforts are also underway to consolidate and improve on the results obtained with systemic CT to preserve laryngeal function. We strongly believe that with continuation of these serious efforts further achievement and impact can be obtained with systemic CT as part of other modalities in these patients. © 1995 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:41 / 53
页数:13
相关论文
共 94 条
[1]   EXCELLENT RESPONSE TO CIS-PLATINUM BASED CHEMOTHERAPY IN PATIENTS WITH RECURRENT OR PREVIOUSLY UNTREATED ADVANCED NASOPHARYNGEAL CARCINOMA [J].
ALKOURAINY, K ;
CRISSMAN, J ;
ENSLEY, J ;
KISH, J ;
KELLY, J ;
ALSARRAF, M .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04) :427-430
[2]  
ALKOURAINY K, 1987, CANCER, V59, P233, DOI 10.1002/1097-0142(19870115)59:2<233::AID-CNCR2820590210>3.0.CO
[3]  
2-X
[4]   CHEMOTHERAPEUTIC MANAGEMENT OF HEAD AND NECK-CANCER [J].
ALSARRAF, M .
CANCER AND METASTASIS REVIEWS, 1987, 6 (03) :181-198
[5]  
ALSARRAF M, 1988, SEMIN ONCOL, V15, P70
[6]   CHEMOTHERAPY STRATEGIES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
ALSARRAF, M .
CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1984, 1 (04) :323-355
[7]   THE WAYNE-STATE-UNIVERSITY EXPERIENCE WITH ADJUVANT CHEMOTHERAPY OF HEAD AND NECK-CANCER [J].
ALSARRAF, M ;
KISH, JA ;
ENSLEY, JF .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (04) :687-700
[8]  
ALSARRAF M, 1987, CANCER-AM CANCER SOC, V59, P259, DOI 10.1002/1097-0142(19870115)59:2<259::AID-CNCR2820590214>3.0.CO
[9]  
2-1
[10]   CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA - A RADIATION-THERAPY ONCOLOGY GROUP-STUDY [J].
ALSARRAF, M ;
PAJAK, TF ;
COOPER, JS ;
MOHIUDDIN, M ;
HERSKOVIC, A ;
AGER, PJ .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) :1342-1351